TrialNature medicine2026

Apitegromab for lean mass preservation during tirzepatide-induced weight loss: a randomized, double-blind, placebo-controlled phase 2 trial.

Richard E Pratley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.